Trevi Therapeutics Wins Analyst Praise As Losses Narrow And Cash Stays Strong FinimizeTrevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates Yahoo FinanceA Peek at Trevi Therapeutics’s Future Earnings BenzingaTrevi Therapeutics to Participate in Stifel 2025 Healthcare Conference PR NewswireTrevi Therapeutics reports Q3 EPS (8c), consensus (10c) TipRanks